Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alten

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|September 25, 2004
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitisJ Braun, J Brandt, J Listing, et al.
Annals of the Rheumatic Diseases|December 21, 2016
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)R Westhovens, P C Taylor, R Alten, et al.
Rheumatology (Oxford, England)|March 11, 2005
Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 yearsJ Braun, X Baraliakos, J Brandt, et al.
Arthritis and Rheumatism|July 14, 1999
No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled studyJ Sieper, C Fendler, S Laitko, et al.
Arthritis and Rheumatism|January 1, 1996
Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trialJ Sieper, S Kary, H Sörensen, et al.
Zeitschrift Fur Rheumatologie|November 2, 2004
[Value of inpatient care in rheumatoid arthritis-an evidence based report]M Schneider, M Lelgemann, C Baerwald, et al.
Zeitschrift Fur Rheumatologie|January 13, 2017
[Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF]U Kiltz, R Alten, M Fleck, et al.
Lancet (London, England)|April 17, 2002
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trialJ Braun, J Brandt, J Listing, et al.
Arthritis and Rheumatism|August 9, 2003
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trialJ Braun, J Brandt, J Listing, et al.
MMW Fortschritte Der Medizin|July 12, 2007
[Current therapeutic strategy for rheumatoid arthritis]J Wollenhaupt, R Alten, H Burkhardt, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|September 25, 2004
Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitisJ Braun, J Brandt, J Listing, et al.
Annals of the Rheumatic Diseases|December 21, 2016
Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)R Westhovens, P C Taylor, R Alten, et al.
Rheumatology (Oxford, England)|March 11, 2005
Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 yearsJ Braun, X Baraliakos, J Brandt, et al.
Arthritis and Rheumatism|July 14, 1999
No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled studyJ Sieper, C Fendler, S Laitko, et al.
Arthritis and Rheumatism|January 1, 1996
Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trialJ Sieper, S Kary, H Sörensen, et al.
Zeitschrift Fur Rheumatologie|November 2, 2004
[Value of inpatient care in rheumatoid arthritis-an evidence based report]M Schneider, M Lelgemann, C Baerwald, et al.
Zeitschrift Fur Rheumatologie|January 13, 2017
[Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF]U Kiltz, R Alten, M Fleck, et al.
Lancet (London, England)|April 17, 2002
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trialJ Braun, J Brandt, J Listing, et al.
Arthritis and Rheumatism|August 9, 2003
Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trialJ Braun, J Brandt, J Listing, et al.
MMW Fortschritte Der Medizin|July 12, 2007
[Current therapeutic strategy for rheumatoid arthritis]J Wollenhaupt, R Alten, H Burkhardt, et al.
Pageof 5